Humana Inc. (HUM) posted third-quarter 2024 adjusted earnings per share (EPS) of $4.16, which surpassed the Zacks Consensus Estimate by 19.5%. However, the bottom line fell from $7.78 per share a year ago. Adjusted revenues improved 14.8% year over year to $29.3 billion. The top line beat the consensus mark by 2.2%. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The better-than-expected quarterly results benefited from strong premium growth, improved operating cost management and ...

Humana Inc. (NYSE:HUM) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President and CEO Susan Diamond - CFO George Renaudin - President, Insurance Conference Call Participants Justin Lake - Wolfe Research Ann Hynes - Mizuho Andrew Mok - Barclays Ben Hendrix - RBC Capital Markets Sarah James - Cantor Fitzgerald Joshua Raskin - Nephron Research Stephen Baxter - Wells Fargo Joanna Gajuk - Bank of America George Hill - Deutsche Bank Whit Ma ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...

For the quarter ended September 2024, Humana (HUM) reported revenue of $29.3 billion, up 14.8% over the same period last year. EPS came in at $4.16, compared to $7.78 in the year-ago quarter.The reported revenue represents a surprise of +2.24% over the Zacks Consensus Estimate of $28.66 billion. With the consensus EPS estimate being $3.48, the EPS surprise was +19.54%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...

Humana (HUM) came out with quarterly earnings of $4.16 per share, beating the Zacks Consensus Estimate of $3.48 per share. This compares to earnings of $7.78 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 19.54%. A quarter ago, it was expected that this health insurer would post earnings of $5.89 per share when it actually produced earnings of $6.96, delivering a surprise of 18.17%. Over the last four quarters, the company ha ...

n e w s r e l e a s e Exhibit 99.2 Humana Inc. 500 West Main Street P.O. Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Lisa Stoner Humana Investor Relations (502) 580-2652 e-mail: LStamper@humana.com Mark Taylor Humana Corporate Communications (317) 753-0345 e-mail: MTaylor108@humana.com Humana Reports Third Quarter 2024 Financial Results; Updates Full Year Adjusted 2024 Financial Guidance • Reports 3Q24 earnings per share (EPS) of $3.98 on a GAAP basis, Adjusted EPS of $ ...

Humana Inc. (HUM) is slated to release third-quarter 2024 results on Oct. 30, before the opening bell. The Zacks Consensus Estimate for earnings per share is pegged at $3.48, which indicates a 55.3% plunge from the prior-year quarter's number. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The third-quarter earnings estimate has witnessed two downward revisions over the past month. During this time, the estimate declined 1.7%. Meanwhile, the Zacks Consensus Estimate for revenues i ...

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Humana Inc. (“Humana” or the “Company”) (NYSE: HUM) on behalf of Humana stockholders. Our investigation concerns whether Humana has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On October 2, 2024, Humana disclosed that it has “approximately 1.6 million, or 2 ...

Shares of Humana Inc (NYSE:HUM) and Cigna Group (NYSE:CI) are making opposite moves today, as merger talks between the health insurance companies ramp up. According to a Bloomberg report that cited people familiar with the matter, the talks are in early stages.At last glance, HUM is 0.5% higher at $268.55. The equity is still down nearly 50% in the past 12 months, with a more than 40% year-to-date deficit to boot. Humana stock could today conquer its 20-day moving average, as it distances itself from its Oc ...

Key TakeawaysHumana shares were sharply higher in premarket trading Monday following a report that Cigna has resumed its efforts to merge with the struggling health insurer.The stock broke down below a descending channel late last month, but promptly reversed course the following week to reclaim the pattern's lower trendline, potentially indicating a bear trap.Investors should watch key overhead levels on Humana's chart around $300, $370 and $450, while also watching a crucial area of support near $230. Hum ...